Impact of Early Oral Antibiotic Therapy in Infants With Bacteremic Urinary Tract Infections

Hosp Pediatr. 2022 Jul 1;12(7):632-638. doi: 10.1542/hpeds.2021-006479.

Abstract

Objectives: To determine the effect of early conversion to oral antibiotics in infants ≤90 days with gram-negative bacteremia and concomitant urinary tract infection on hospital length of stay (LOS) and 30-day revisits for urinary tract infection.

Design: This retrospective cohort study included infants ≤ 90 days who had concomitant positive blood and urine cultures with gram-negative bacteremia at 22 hospitals from January 1, 2002 through January 31, 2020. Early oral conversion was defined as a maximum intravenous (IV) duration of 4 days. We conducted a noninferiority test to compare early oral conversion to long IV therapy. A propensity score framework was used to assess comparisons in survey-weighted regression models using matched weights.

Results: Among 174 infants, 73 infants received early oral conversion. The LOS was shorter in infants receiving early oral conversion compared to long IV therapy (median 2 days [interquartile range 2, 3] vs 4 days [3, 5]), descriptively (P < .001) and in noninferiority analysis (ratio = 0.43; 90% CI 0.35, 0.53, P < .001). Thirty-day revisits occurred in 5 of 174 (2.8%) of total patients. Early oral conversion did not meet our noninferiority criteria for the 30-day revisits (odds ratio: 4.22, 90%; confidence interval: 0.83, 21.34, P = .91).

Conclusions: Early oral conversion was associated with shorter LOS. The rate of 30-day revisit rates overall was low.

MeSH terms

  • Administration, Oral
  • Anti-Bacterial Agents / therapeutic use
  • Bacteremia* / complications
  • Bacteremia* / drug therapy
  • Humans
  • Infant
  • Retrospective Studies
  • Urinary Tract Infections* / complications
  • Urinary Tract Infections* / drug therapy

Substances

  • Anti-Bacterial Agents